Built By Scientists, For Scientists
Labviva connects researchers with suppliers of reagents, chemicals, and instrumentation in an intuitive user-friendly platform that supports the priorities of scientists while staying compliant with purchasing rules. Suppliers can easily manage their content of their products. Products are mapped into scientific applications, techniques and protocols, then a relevant a citation index score is generated based on references in peer reviewed journal and related documents and assets are compiled. The results are a unique index of products linked to the relevancy of a product with each scientific use case.
At Labviva, our mission is to accelerate the pace of life science research by connecting suppliers, purchasing departments, and scientists through AI. We integrate with industry-leading procurement systems to shorten implementation times and reduce disruptions to the lab. We build partnerships across the entire ecosystem and use technology to create connections.
Labviva connects researchers with suppliers of reagents, chemicals, and instrumentation in an intuitive user-friendly platform that supports the priorities of scientists while staying compliant with purchasing rules. Suppliers can easily manage their content of their products. Products are mapped into scientific applications, techniques and protocols, then a relevant a citation index score is generated based on references in peer reviewed journal and related documents and assets are compiled. The results are a unique index of products linked to the relevancy of a product with each scientific use case.
At Labviva, our mission is to accelerate the pace of life science research by connecting suppliers, purchasing departments, and scientists through AI. We integrate with industry-leading procurement systems to shorten implementation times and reduce disruptions to the lab. We build partnerships across the entire ecosystem and use technology to create connections.
Location: United States, Massachusetts, Boston
Employees: 51-200
Total raised: $53M
Founded date: 2017
Investors 9
Funding Rounds 3
| Date | Series | Amount | Investors |
| 16.01.2025 | Series B | $25M | - |
| 29.03.2023 | Series A | $20M | - |
| 21.06.2021 | Seed | $8M | - |
Mentions in press and media 16
| Date | Title | Description |
| 16.01.2025 | Labviva: $25 Million (Series B) Raised For Accelerating Life Sciences Product Development | Labviva, a leading AI procurement platform for life sciences, announced the closing of its $25 million Series B, bringing the total funding to $55 million. The round was led by 53 Stations, with continued participation from Biospring Partne... |
| 14.01.2025 | Labviva's $25 Million Boost: A Leap into the Future of Life Sciences Procurement | In the fast-paced world of life sciences, efficiency is king. Labviva, a Boston-based startup, has just secured a significant $25 million in Series B funding. This infusion of capital is not just a financial boost; it’s a ticket to the futu... |
| 13.01.2025 | Labviva Secures $25M to Accelerate Product Development and Global Expansion | BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Labviva, the leading AI procurement platform for life sciences, today announced the close of its $25 million Series B, bringing its total funding to $55 million. Led by 53 Stations, with continued p... |
| 13.01.2025 | Labviva Raises $25M in Series B Funding | Labviva, a Boston, MA-based provider of an AI procurement platform for life sciences, raised $25M in Series B funding. The round was led by 53 Stations, with participation from Biospring Partners, B Capital Group, and Glasswing Ventures. As... |
| 13.01.2025 | Labviva raises $25M to boost AI-powered life sciences procurement platform Your vote of support is important to us and it helps us keep the content FREE. One click below supports our mission to provid... | Labviva Inc., a startup offering an artificial intelligence procurement platform for life sciences, announced today that it has raised $25 million in new funding to accelerate product innovation, enhance marketing and customer support, and ... |
| 29.03.2023 | B Capital backs $20m Series A funding of life-science supply marketplace Labviva | Singapore- and San Francisco-based venture capital investor B Capital has backed the $20-million Series A funding in American life-science digital marketplace Labviva, according to an announcement. Labviva, which uses AI to simplify and sca... |
| 28.03.2023 | Labviva Raises $20M, Plans to Hire 30 Employees Jobs at Labviva | Labviva was co-founded by CTO Nicholas Rioux (left) and CEO Siamak Baharloo (right). | Photo: Labviva Boston-based Labviva announced Monday it raised $20 million to grow its artificial intelligence-powered marketplace that makes it easier f... |
| 28.03.2023 | Labviva Secures $20 Million in Series A Financing to Transform the Life Sciences Procurement Industry Using AI | – Funding led by Biospring Partners with participation from existing investors. Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced that it has secured $20 million in Series A ... |
| 27.03.2023 | Labviva Raises $20M in Series A Financing | Labviva, a Boston, MA-based AI-driven life sciences digital marketplace, raised $20M in Series A funding. The round, which brought the total amount raised since inception to $30M, was led by Biospring Partners, with participation from exist... |
| 27.03.2023 | See the 14-slide pitch deck Labviva used to raise $20 million to overhaul a crucial but overlooked task for Big Pharma | Labviva cofounders Nicholas Rioux and Siamak Baharloo Labviva This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Looking for the right lab supplies and products takes valuable time for resea... |
Show more